Wolwo Pharma(SZ:300357) Xin Lang Cai Jing·2025-11-03 10:54Core Viewpoint - Zhejiang Iwu Biological Technology Co., Ltd. has disclosed the progress of a lawsuit against Shanghai Lihui Equity Investment Partnership and others for violating stock reduction commitments, with a first-instance judgment ordering the defendants to pay 10.96 million yuan plus interest [1][3]. Group 1: Lawsuit Background and Progress - The lawsuit originated from Shanghai Lihui and others violating commitments related to stock reduction. The court accepted the case on September 6, 2024, with multiple defendants including Shanghai Lihui and Shanghai Yixu Medical Technology Co., Ltd. [2]. Group 2: First-instance Judgment Details - The Shanghai Pudong New Area People's Court ruled on October 31, 2025, that Shanghai Lihui must pay 10.96 million yuan within ten days of the judgment becoming effective, along with interest calculated based on specified rates from different dates [3]. - Shanghai Yixu is jointly liable for the payment, while claims against other defendants were dismissed. The case incurred a total of 114,900 yuan in court fees, to be shared by Shanghai Lihui and Shanghai Yixu [3]. Group 3: Other Litigation Matters - The company and its subsidiaries have two additional minor lawsuits not previously disclosed, with amounts of 833,100 yuan and 1,633,600 yuan, respectively. These minor lawsuits have not significantly impacted the company's operations [4].